Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.
about
Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanomaCentral nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens.Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes.
P2860
Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@ast
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@en
type
label
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@ast
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@en
prefLabel
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@ast
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@en
P2093
P1433
P1476
Biochemotherapy with temozolom ...... ents with metastatic melanoma.
@en
P2093
Begona Mellado
Carlos Conill
Joseph Herrero
Joseph Malvehy
Marcelo Sánchez
Marta Martín
María González Cao
Pere Gascón
Rosa Martí
Teresa Castel
P356
10.1097/01.CMR.0000195697.58013.B7
P407
P577
2006-02-01T00:00:00Z